Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke：Longterm Outcome (OPENS-3L)

NCT05965193 is registered in ClinicalTrials.gov with Ji Xunming,MD,PhD as lead sponsor.

NCT NCT05965193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05965193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke：Longterm Outcome (OPENS-3L)
Lead sponsor
Ji Xunming,MD,PhD
Phase
Phase 3
Overall status
Unknown status
Start date
August 17, 2023
Completion date
October 30, 2025
Enrollment
1,230 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke